Being a Study Participant

Stages 2 and 3

TAKE-IT TOO is split up into three different stages.

Each stage will have a different type of participation from

the participant, patient, or health care professional.

Stage 1- Completed

Stage 2- Ongoing, see below for details

Stage 3- Ongoing, see below for details

Patient Participation

     Stage 2

Time Commitment: 2 hours per session for 3 sessions over a 2-year period, plus 3 weeks of using the new electronic pillbox at home.

Patients will look at different possible models of a new electronic pillbox and give feedback. They will have the chance to contribute to what a new device will be like. As development of the new electronic pillbox progresses, they will get to try more and more developed models. Finally, they will test the final prototype at home for 3 weeks by using it to store their medications.

  

     Stage 3

Participants of stage 3 will use the novel TAKE-IT TOO e-pillbox to store their medications and have their medication-taking tracked. Patients at intervention centres will also meet with a coach at regular intervals and will be able to track their own adherence on a companion website or app. Patients at usual care sites will only use the pillbox but will not meet with a coach and will not be able to use the tracking website or app until the study is finished. If they want to continue using the pillbox and have access to the tracking website, they will be allowed to do this for a period of 20 weeks after the end of the study. 

  

Parent Participation

     Stage 2

Time Commitment: Parents aren’t required to participate in Stage 2. However, parents are welcome to accompany their participating child for 3 sessions of 2 hours each for over a 2-year period, plus 3 weeks of using the new electronic pillbox at home.

     Stage 3

Parents of patients participating in stage 3 will support their child in the use the novel TAKE-IT TOO e-pillbox. Patients and their parents at intervention centres will also meet with a coach at regular intervals and will be able to track their own adherence on a companion website or app. Patients and their parents at usual care sites will only use the pillbox but will not meet with a coach and will not be able to use the tracking website or app until the study is finished. If they want to continue using the pillbox and have access to the tracking website, they will be allowed to do this for a period of 20 weeks after the end of the study. 

Healthcare Professional Participation

     Stage 2

Time Commitment: 2 hours per session for 3 sessions over a 2-year period, plus 3 weeks of using the new electronic pillbox tracking website at work.

Healthcare professionals will look at different possible adherence tracking website or mobile app designs and give feedback. They will have the chance to contribute to what a new adherence tracking website or mobile app will be like. As development of the new electronic pillbox and adherence tracking website or mobile app progresses, they will get to try more and more developed versions. Finally, they will test the final design at work for 3 weeks by using it to track adherence in a small number of patients who are testing the new pillbox at home.

     Stage 3

Time Commitment: variable 

Healthcare professionals at intervention centers will be able to track the adherence of participating patients at their site via the new tracking website and/or mobile app. They will also interact with the study coach regularly to discuss how to help participants improve adherence. Healthcare professionals at usual care sites will provide their usual care. When the study is finished, professionals at usual care sites will have access to the tracking website, they will be allowed use it for patients who continue to use the electronic pillbox for a period of 20 weeks after the end of the study.